Zhongzhi Pharmaceutical Holdings Limited

As of June 30, 2025, Zhongzhi Pharmaceutical Holdings Limited carries a market capitalization of 742.50M, placing it among publicly traded companies globally. Its enterprise value stands at 896.92M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2025, Zhongzhi Pharmaceutical Holdings Limited has 843.74M shares outstanding.

These figures are as of June 30, 2025.

As of June 30, 2025, Zhongzhi Pharmaceutical Holdings Limited maintains a current ratio of 1.54, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2025.

As of the close on October 22, 2026, Zhongzhi Pharmaceutical Holdings Limited's stock has declined approximately 6.82% over the past 52 weeks. The 50-day moving average sits at 0.70, while the 200-day moving average is 0.74.

As of June 30, 2025, Zhongzhi Pharmaceutical Holdings Limited holds 159.44M in cash and equivalents against 308.33M in total debt, resulting in a net debt position of 48.82M. Total book value stands at 1.19B, with working capital of 372.59M providing operational flexibility.